Presence of elevated antibody titres to Epstein-Barr virus before Hodgkin's disease (Q44233037)

1 December 2017

title

Presence of elevated antibody titres to Epstein-Barr virus before Hodgkin's disease (English)

1 reference

1 December 2017

1 reference

A S Evans

1

1 reference

1 December 2017

G W Comstock

series ordinal

2

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 May 1981

1 reference

1 December 2017

1 reference

1 December 2017

volume

1

1 reference

1 December 2017

issue

8231

1 reference

1 December 2017

page(s)

1183-1186

1 reference

Epidemiology of hodgkin's disease in the young

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Childhood Social Environment and Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). I Reticuloproliferative disease in an inoculated animal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Seroepidemiologic Studies of Infectious Mononucleosis with Eb Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Infectious mononucleosis and the empirical risk of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Hodgkin's disease in patients with previous infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Cancer incidence following infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Infectious mononucleosis and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Incidence of antibody to EB virus, herpes simplex, and cytomegalovirus in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Antibodies to Epstein-Barr virus, cytomegalovirus, and Australia antigen in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

The search for a viral agent in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-vical antigens in Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Antibodies to epstein-barr virus in patients with Hodgkin's disease and leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

A case control study on immunity to two epstein-barr virus-associated antigens, and to herpes simplex virus and adenovirus in a population-based group of patients with hodgkin's disease in denmark, 1971–73

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Epstein-Barr Virus Infections in Brazil. II. Hodgkin's Disease2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

A CASE-CONTROL STUDY OF HODGKIN'S DISEASE IN BRAZIL

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

A case-control study of Hodgkin's disease in Brazil II. Seroepidemiologic studies in cases and family members

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

EB-virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens(EA) in patients with various neoplastic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Longitudinal study of epstein-barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

The relation between epstein-barr virus antibodies and clinical symptomatology and immunodeficiency in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Absence of Epstein-Barr viral DNA in Amercian Burkitt's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Attempts to detect virus-specific DNA in human tumors. II. Nucleic acid hybridizations with complementary RNA of human herpes group viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

A Prospective Evaluation of Heterophile and Epstein-Barr Virus-Specific IgM Antibody Tests in Clinical and Subclinical Infectious Mononucleosis: Specificity and Sensitivity of the Tests and Persistence of Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

EB virus-specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Serum IgA antibodies to Epstein-Barr virus capsid antigen preceding symptoms of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Application of an Immunoenzymatic Method and an Immunoautoradiographic Method for a Mass Survey of Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Epstein-Barr virus-specific antibody titers in seven Alaskan Natives before and after diagnosis of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

A seroepidemiological study of Epstein-Barr virus and other viral antigens in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Clinical and laboratory aspects of raised virus antibody titres in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Establishment of a malignant, epstein-barr-virus (EBV)-negative cell-line from the pleura effusion of a patient with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Two neoplastic cell lines with unique features derived from Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Depression of cell-mediated immunity during acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2992351-5

7 January 2021

10.1016/S0140-6736(81)92351-5

Identifiers

DOI

1 reference

1 December 2017

1 reference